Epidemiology & Forecasting

Decision Resources offers the industry’s leading epidemiology and market forecasts for the world’s most significant diseases.

Epidemiology
Decision Resources’ epidemiology analyses quantify the relative burden of disease in major pharmaceutical markets. Our estimates provide the starting point for experienced analysts to model their own markets. The country-specific data we include in our analyses are recognized as the premier epidemiology in the industry.

Our epidemiology information includes:

• Prevalence and/or incidence
• Diagnosed percentage and population
• Drug-treated percentage and population
• Country
• Gender
• Age
• Comorbidity
• Relevant disease subpopulations, including severity, lab measure, discharge diagnosis, time to presentation, seasonality, and subtype.
  

The following product lines include our comprehensive epidemiological analyses:

• PatientBase
• Pharmacor
• DecisionBase

Market Forecasts
The backbone of our Pharmacor reports, market forecasts drive the decision-making of our pharmaceutical, biotechnology, and financial clients. With 5- and 10-year forecasts (in some cases, 15-year), our reports predict the success or failure of current and emerging drugs.

Each Pharmacor report comes with the Interactive Forecast Tool, which is a Microsoft Excel spreadsheet used to build a seven-country market forecast based on Decision Resources' patient-based market models. This file contains Decision Resources' market forecast data, tables, and conclusions. Clients have the option to add as many as ten additional entries for interactive, custom market forecasts. This application permits detailed "what-if" analyses of Decision Resources' patient-based five- and ten-year forecasts.

The following product lines include market forecasts:

The Interactive Forecast Tool --- Pharmacor’s Premier Forecasting Data Set

The following product lines include information to assist with planning a market forecast:  

Target Product Profiles
DecisionBase